nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—SLC22A2—Estradiol—osteoporosis	0.136	0.244	CbGbCtD
Flurazepam—ABCB1—Ethinyl Estradiol—osteoporosis	0.056	0.101	CbGbCtD
Flurazepam—CYP3A4—Calcitriol—osteoporosis	0.0521	0.0937	CbGbCtD
Flurazepam—CYP3A4—Estropipate—osteoporosis	0.0521	0.0937	CbGbCtD
Flurazepam—CYP3A4—Ergocalciferol—osteoporosis	0.0416	0.0749	CbGbCtD
Flurazepam—ABCB1—Conjugated Estrogens—osteoporosis	0.0411	0.0739	CbGbCtD
Flurazepam—ABCB1—Estradiol—osteoporosis	0.0361	0.0649	CbGbCtD
Flurazepam—CYP3A4—Raloxifene—osteoporosis	0.0347	0.0625	CbGbCtD
Flurazepam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0336	0.0604	CbGbCtD
Flurazepam—CYP3A4—Cholecalciferol—osteoporosis	0.0268	0.0483	CbGbCtD
Flurazepam—CYP3A4—Conjugated Estrogens—osteoporosis	0.0246	0.0443	CbGbCtD
Flurazepam—CYP3A4—Estradiol—osteoporosis	0.0216	0.0389	CbGbCtD
Flurazepam—Anaphylactic shock—Ibandronate—osteoporosis	0.00137	0.00312	CcSEcCtD
Flurazepam—Dry mouth—Calcitriol—osteoporosis	0.00137	0.00311	CcSEcCtD
Flurazepam—Shock—Raloxifene—osteoporosis	0.00136	0.0031	CcSEcCtD
Flurazepam—Feeling abnormal—Etidronic acid—osteoporosis	0.00136	0.0031	CcSEcCtD
Flurazepam—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00135	0.00307	CcSEcCtD
Flurazepam—Shock—Ibandronate—osteoporosis	0.00135	0.00307	CcSEcCtD
Flurazepam—Anaphylactic shock—Calcitriol—osteoporosis	0.00134	0.00305	CcSEcCtD
Flurazepam—Hyperhidrosis—Raloxifene—osteoporosis	0.00134	0.00304	CcSEcCtD
Flurazepam—Hyperhidrosis—Ibandronate—osteoporosis	0.00132	0.00301	CcSEcCtD
Flurazepam—Nausea—Ergocalciferol—osteoporosis	0.00132	0.003	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Estropipate—osteoporosis	0.0013	0.00296	CcSEcCtD
Flurazepam—Tension—Pamidronate—osteoporosis	0.00129	0.00294	CcSEcCtD
Flurazepam—Dysgeusia—Pamidronate—osteoporosis	0.00129	0.00293	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00128	0.00292	CcSEcCtD
Flurazepam—Flushing—Zoledronate—osteoporosis	0.00128	0.00291	CcSEcCtD
Flurazepam—Anorexia—Calcitriol—osteoporosis	0.00128	0.00291	CcSEcCtD
Flurazepam—Nervousness—Pamidronate—osteoporosis	0.00128	0.00291	CcSEcCtD
Flurazepam—Abdominal discomfort—Estradiol—osteoporosis	0.00127	0.0029	CcSEcCtD
Flurazepam—Somnolence—Estropipate—osteoporosis	0.00127	0.00289	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00126	0.00287	CcSEcCtD
Flurazepam—Dyspepsia—Estropipate—osteoporosis	0.00126	0.00286	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00125	0.00284	CcSEcCtD
Flurazepam—Syncope—Risedronate—osteoporosis	0.00124	0.00282	CcSEcCtD
Flurazepam—Dyspepsia—Alendronate—osteoporosis	0.00124	0.00282	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00122	0.00278	CcSEcCtD
Flurazepam—Constipation—Estropipate—osteoporosis	0.00122	0.00278	CcSEcCtD
Flurazepam—Dyspepsia—Raloxifene—osteoporosis	0.00122	0.00277	CcSEcCtD
Flurazepam—Loss of consciousness—Risedronate—osteoporosis	0.00122	0.00277	CcSEcCtD
Flurazepam—Agitation—Pamidronate—osteoporosis	0.00121	0.00275	CcSEcCtD
Flurazepam—Dyspepsia—Ibandronate—osteoporosis	0.00121	0.00274	CcSEcCtD
Flurazepam—Anxiety—Ethinyl Estradiol—osteoporosis	0.0012	0.00274	CcSEcCtD
Flurazepam—Constipation—Alendronate—osteoporosis	0.0012	0.00274	CcSEcCtD
Flurazepam—Somnolence—Calcitriol—osteoporosis	0.00119	0.00271	CcSEcCtD
Flurazepam—Decreased appetite—Ibandronate—osteoporosis	0.00119	0.00271	CcSEcCtD
Flurazepam—Syncope—Pamidronate—osteoporosis	0.00118	0.00268	CcSEcCtD
Flurazepam—Arthralgia—Risedronate—osteoporosis	0.00118	0.00268	CcSEcCtD
Flurazepam—Chest pain—Risedronate—osteoporosis	0.00118	0.00268	CcSEcCtD
Flurazepam—Leukopenia—Pamidronate—osteoporosis	0.00118	0.00268	CcSEcCtD
Flurazepam—Dysgeusia—Zoledronate—osteoporosis	0.00118	0.00268	CcSEcCtD
Flurazepam—Anxiety—Risedronate—osteoporosis	0.00117	0.00267	CcSEcCtD
Flurazepam—Constipation—Ibandronate—osteoporosis	0.00117	0.00267	CcSEcCtD
Flurazepam—Pruritus—Etidronic acid—osteoporosis	0.00117	0.00266	CcSEcCtD
Flurazepam—Gastrointestinal pain—Estropipate—osteoporosis	0.00117	0.00266	CcSEcCtD
Flurazepam—Decreased appetite—Calcitriol—osteoporosis	0.00117	0.00265	CcSEcCtD
Flurazepam—Feeling abnormal—Alendronate—osteoporosis	0.00116	0.00264	CcSEcCtD
Flurazepam—Loss of consciousness—Pamidronate—osteoporosis	0.00116	0.00263	CcSEcCtD
Flurazepam—Dry mouth—Risedronate—osteoporosis	0.00115	0.00262	CcSEcCtD
Flurazepam—Gastrointestinal pain—Alendronate—osteoporosis	0.00115	0.00262	CcSEcCtD
Flurazepam—Constipation—Calcitriol—osteoporosis	0.00115	0.00261	CcSEcCtD
Flurazepam—Tension—Conjugated Estrogens—osteoporosis	0.00114	0.00258	CcSEcCtD
Flurazepam—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00113	0.00258	CcSEcCtD
Flurazepam—Vision blurred—Zoledronate—osteoporosis	0.00113	0.00258	CcSEcCtD
Flurazepam—Gastrointestinal pain—Raloxifene—osteoporosis	0.00113	0.00258	CcSEcCtD
Flurazepam—Diarrhoea—Etidronic acid—osteoporosis	0.00113	0.00257	CcSEcCtD
Flurazepam—Feeling abnormal—Ibandronate—osteoporosis	0.00113	0.00257	CcSEcCtD
Flurazepam—Nervousness—Conjugated Estrogens—osteoporosis	0.00112	0.00256	CcSEcCtD
Flurazepam—Gastrointestinal pain—Ibandronate—osteoporosis	0.00112	0.00255	CcSEcCtD
Flurazepam—Arthralgia—Pamidronate—osteoporosis	0.00112	0.00255	CcSEcCtD
Flurazepam—Anxiety—Pamidronate—osteoporosis	0.00112	0.00254	CcSEcCtD
Flurazepam—Shock—Risedronate—osteoporosis	0.00111	0.00253	CcSEcCtD
Flurazepam—Agitation—Zoledronate—osteoporosis	0.0011	0.00251	CcSEcCtD
Flurazepam—Gastrointestinal pain—Calcitriol—osteoporosis	0.0011	0.0025	CcSEcCtD
Flurazepam—Vision blurred—Conjugated Estrogens—osteoporosis	0.00109	0.00248	CcSEcCtD
Flurazepam—Confusional state—Pamidronate—osteoporosis	0.00108	0.00246	CcSEcCtD
Flurazepam—Syncope—Zoledronate—osteoporosis	0.00108	0.00245	CcSEcCtD
Flurazepam—Leukopenia—Zoledronate—osteoporosis	0.00108	0.00245	CcSEcCtD
Flurazepam—Anaphylactic shock—Pamidronate—osteoporosis	0.00107	0.00244	CcSEcCtD
Flurazepam—Palpitations—Zoledronate—osteoporosis	0.00106	0.00242	CcSEcCtD
Flurazepam—Shock—Pamidronate—osteoporosis	0.00106	0.0024	CcSEcCtD
Flurazepam—Loss of consciousness—Zoledronate—osteoporosis	0.00106	0.0024	CcSEcCtD
Flurazepam—Vomiting—Etidronic acid—osteoporosis	0.00105	0.00239	CcSEcCtD
Flurazepam—Rash—Etidronic acid—osteoporosis	0.00104	0.00237	CcSEcCtD
Flurazepam—Dermatitis—Etidronic acid—osteoporosis	0.00104	0.00237	CcSEcCtD
Flurazepam—Hyperhidrosis—Pamidronate—osteoporosis	0.00104	0.00236	CcSEcCtD
Flurazepam—Syncope—Conjugated Estrogens—osteoporosis	0.00104	0.00236	CcSEcCtD
Flurazepam—Headache—Etidronic acid—osteoporosis	0.00103	0.00235	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00103	0.00234	CcSEcCtD
Flurazepam—Asthenia—Estropipate—osteoporosis	0.00103	0.00233	CcSEcCtD
Flurazepam—Anorexia—Pamidronate—osteoporosis	0.00102	0.00233	CcSEcCtD
Flurazepam—Arthralgia—Zoledronate—osteoporosis	0.00102	0.00233	CcSEcCtD
Flurazepam—Chest pain—Zoledronate—osteoporosis	0.00102	0.00233	CcSEcCtD
Flurazepam—Palpitations—Conjugated Estrogens—osteoporosis	0.00102	0.00233	CcSEcCtD
Flurazepam—Anxiety—Zoledronate—osteoporosis	0.00102	0.00232	CcSEcCtD
Flurazepam—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00102	0.00231	CcSEcCtD
Flurazepam—Pruritus—Estropipate—osteoporosis	0.00101	0.0023	CcSEcCtD
Flurazepam—Asthenia—Alendronate—osteoporosis	0.00101	0.0023	CcSEcCtD
Flurazepam—Dyspnoea—Risedronate—osteoporosis	0.00101	0.00229	CcSEcCtD
Flurazepam—Hypotension—Pamidronate—osteoporosis	0.001	0.00228	CcSEcCtD
Flurazepam—Dry mouth—Zoledronate—osteoporosis	0.001	0.00228	CcSEcCtD
Flurazepam—Pruritus—Alendronate—osteoporosis	0.000996	0.00227	CcSEcCtD
Flurazepam—Dyspepsia—Risedronate—osteoporosis	0.000994	0.00226	CcSEcCtD
Flurazepam—Constipation—Ethinyl Estradiol—osteoporosis	0.000991	0.00225	CcSEcCtD
Flurazepam—Confusional state—Zoledronate—osteoporosis	0.000989	0.00225	CcSEcCtD
Flurazepam—Flushing—Estradiol—osteoporosis	0.000987	0.00225	CcSEcCtD
Flurazepam—Arthralgia—Conjugated Estrogens—osteoporosis	0.000985	0.00224	CcSEcCtD
Flurazepam—Chest pain—Conjugated Estrogens—osteoporosis	0.000985	0.00224	CcSEcCtD
Flurazepam—Asthenia—Ibandronate—osteoporosis	0.000983	0.00224	CcSEcCtD
Flurazepam—Anxiety—Conjugated Estrogens—osteoporosis	0.000982	0.00223	CcSEcCtD
Flurazepam—Nausea—Etidronic acid—osteoporosis	0.000981	0.00223	CcSEcCtD
Flurazepam—Anaphylactic shock—Zoledronate—osteoporosis	0.000981	0.00223	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000978	0.00223	CcSEcCtD
Flurazepam—Diarrhoea—Estropipate—osteoporosis	0.000978	0.00222	CcSEcCtD
Flurazepam—Pruritus—Ibandronate—osteoporosis	0.00097	0.00221	CcSEcCtD
Flurazepam—Constipation—Risedronate—osteoporosis	0.000966	0.0022	CcSEcCtD
Flurazepam—Shock—Zoledronate—osteoporosis	0.000965	0.00219	CcSEcCtD
Flurazepam—Diarrhoea—Alendronate—osteoporosis	0.000963	0.00219	CcSEcCtD
Flurazepam—Asthenia—Calcitriol—osteoporosis	0.000963	0.00219	CcSEcCtD
Flurazepam—Dyspnoea—Pamidronate—osteoporosis	0.000957	0.00218	CcSEcCtD
Flurazepam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000955	0.00217	CcSEcCtD
Flurazepam—Somnolence—Pamidronate—osteoporosis	0.000955	0.00217	CcSEcCtD
Flurazepam—Pruritus—Calcitriol—osteoporosis	0.000949	0.00216	CcSEcCtD
Flurazepam—Hyperhidrosis—Zoledronate—osteoporosis	0.000948	0.00216	CcSEcCtD
Flurazepam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000947	0.00215	CcSEcCtD
Flurazepam—Diarrhoea—Raloxifene—osteoporosis	0.000947	0.00215	CcSEcCtD
Flurazepam—Dyspepsia—Pamidronate—osteoporosis	0.000945	0.00215	CcSEcCtD
Flurazepam—Dizziness—Estropipate—osteoporosis	0.000945	0.00215	CcSEcCtD
Flurazepam—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000944	0.00215	CcSEcCtD
Flurazepam—Diarrhoea—Ibandronate—osteoporosis	0.000938	0.00213	CcSEcCtD
Flurazepam—Anorexia—Zoledronate—osteoporosis	0.000935	0.00213	CcSEcCtD
Flurazepam—Decreased appetite—Pamidronate—osteoporosis	0.000933	0.00212	CcSEcCtD
Flurazepam—Dizziness—Alendronate—osteoporosis	0.000931	0.00212	CcSEcCtD
Flurazepam—Shock—Conjugated Estrogens—osteoporosis	0.000929	0.00211	CcSEcCtD
Flurazepam—Gastrointestinal pain—Risedronate—osteoporosis	0.000924	0.0021	CcSEcCtD
Flurazepam—Constipation—Pamidronate—osteoporosis	0.000918	0.00209	CcSEcCtD
Flurazepam—Diarrhoea—Calcitriol—osteoporosis	0.000918	0.00209	CcSEcCtD
Flurazepam—Hypotension—Zoledronate—osteoporosis	0.000916	0.00208	CcSEcCtD
Flurazepam—Dizziness—Raloxifene—osteoporosis	0.000916	0.00208	CcSEcCtD
Flurazepam—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000913	0.00208	CcSEcCtD
Flurazepam—Tension—Estradiol—osteoporosis	0.000909	0.00207	CcSEcCtD
Flurazepam—Vomiting—Estropipate—osteoporosis	0.000909	0.00207	CcSEcCtD
Flurazepam—Dysgeusia—Estradiol—osteoporosis	0.000907	0.00206	CcSEcCtD
Flurazepam—Dizziness—Ibandronate—osteoporosis	0.000906	0.00206	CcSEcCtD
Flurazepam—Rash—Estropipate—osteoporosis	0.000901	0.00205	CcSEcCtD
Flurazepam—Dermatitis—Estropipate—osteoporosis	0.0009	0.00205	CcSEcCtD
Flurazepam—Anorexia—Conjugated Estrogens—osteoporosis	0.0009	0.00205	CcSEcCtD
Flurazepam—Nervousness—Estradiol—osteoporosis	0.000899	0.00205	CcSEcCtD
Flurazepam—Headache—Estropipate—osteoporosis	0.000895	0.00204	CcSEcCtD
Flurazepam—Vomiting—Alendronate—osteoporosis	0.000895	0.00204	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000894	0.00203	CcSEcCtD
Flurazepam—Rash—Alendronate—osteoporosis	0.000888	0.00202	CcSEcCtD
Flurazepam—Dermatitis—Alendronate—osteoporosis	0.000887	0.00202	CcSEcCtD
Flurazepam—Feeling abnormal—Pamidronate—osteoporosis	0.000885	0.00201	CcSEcCtD
Flurazepam—Hypotension—Conjugated Estrogens—osteoporosis	0.000882	0.00201	CcSEcCtD
Flurazepam—Headache—Alendronate—osteoporosis	0.000882	0.00201	CcSEcCtD
Flurazepam—Vomiting—Raloxifene—osteoporosis	0.00088	0.002	CcSEcCtD
Flurazepam—Gastrointestinal pain—Pamidronate—osteoporosis	0.000878	0.002	CcSEcCtD
Flurazepam—Dyspnoea—Zoledronate—osteoporosis	0.000874	0.00199	CcSEcCtD
Flurazepam—Rash—Raloxifene—osteoporosis	0.000873	0.00199	CcSEcCtD
Flurazepam—Dermatitis—Raloxifene—osteoporosis	0.000872	0.00198	CcSEcCtD
Flurazepam—Somnolence—Zoledronate—osteoporosis	0.000872	0.00198	CcSEcCtD
Flurazepam—Vomiting—Ibandronate—osteoporosis	0.000871	0.00198	CcSEcCtD
Flurazepam—Headache—Raloxifene—osteoporosis	0.000867	0.00197	CcSEcCtD
Flurazepam—Rash—Ibandronate—osteoporosis	0.000864	0.00197	CcSEcCtD
Flurazepam—Dermatitis—Ibandronate—osteoporosis	0.000863	0.00196	CcSEcCtD
Flurazepam—Dyspepsia—Zoledronate—osteoporosis	0.000863	0.00196	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00086	0.00196	CcSEcCtD
Flurazepam—Headache—Ibandronate—osteoporosis	0.000859	0.00195	CcSEcCtD
Flurazepam—Vomiting—Calcitriol—osteoporosis	0.000853	0.00194	CcSEcCtD
Flurazepam—Decreased appetite—Zoledronate—osteoporosis	0.000853	0.00194	CcSEcCtD
Flurazepam—Agitation—Estradiol—osteoporosis	0.000851	0.00194	CcSEcCtD
Flurazepam—Nausea—Estropipate—osteoporosis	0.000849	0.00193	CcSEcCtD
Flurazepam—Rash—Calcitriol—osteoporosis	0.000846	0.00192	CcSEcCtD
Flurazepam—Dermatitis—Calcitriol—osteoporosis	0.000845	0.00192	CcSEcCtD
Flurazepam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000842	0.00192	CcSEcCtD
Flurazepam—Headache—Calcitriol—osteoporosis	0.000841	0.00191	CcSEcCtD
Flurazepam—Somnolence—Conjugated Estrogens—osteoporosis	0.00084	0.00191	CcSEcCtD
Flurazepam—Constipation—Zoledronate—osteoporosis	0.000839	0.00191	CcSEcCtD
Flurazepam—Nausea—Alendronate—osteoporosis	0.000836	0.0019	CcSEcCtD
Flurazepam—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000831	0.00189	CcSEcCtD
Flurazepam—Asthenia—Ethinyl Estradiol—osteoporosis	0.000831	0.00189	CcSEcCtD
Flurazepam—Syncope—Estradiol—osteoporosis	0.000831	0.00189	CcSEcCtD
Flurazepam—Nausea—Raloxifene—osteoporosis	0.000822	0.00187	CcSEcCtD
Flurazepam—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000821	0.00187	CcSEcCtD
Flurazepam—Pruritus—Ethinyl Estradiol—osteoporosis	0.00082	0.00186	CcSEcCtD
Flurazepam—Palpitations—Estradiol—osteoporosis	0.000818	0.00186	CcSEcCtD
Flurazepam—Nausea—Ibandronate—osteoporosis	0.000814	0.00185	CcSEcCtD
Flurazepam—Loss of consciousness—Estradiol—osteoporosis	0.000814	0.00185	CcSEcCtD
Flurazepam—Asthenia—Risedronate—osteoporosis	0.00081	0.00184	CcSEcCtD
Flurazepam—Feeling abnormal—Zoledronate—osteoporosis	0.000808	0.00184	CcSEcCtD
Flurazepam—Constipation—Conjugated Estrogens—osteoporosis	0.000808	0.00184	CcSEcCtD
Flurazepam—Gastrointestinal pain—Zoledronate—osteoporosis	0.000802	0.00182	CcSEcCtD
Flurazepam—Pruritus—Risedronate—osteoporosis	0.000799	0.00182	CcSEcCtD
Flurazepam—Nausea—Calcitriol—osteoporosis	0.000797	0.00181	CcSEcCtD
Flurazepam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000793	0.0018	CcSEcCtD
Flurazepam—Arthralgia—Estradiol—osteoporosis	0.000788	0.00179	CcSEcCtD
Flurazepam—Chest pain—Estradiol—osteoporosis	0.000788	0.00179	CcSEcCtD
Flurazepam—Anxiety—Estradiol—osteoporosis	0.000786	0.00179	CcSEcCtD
Flurazepam—Diarrhoea—Risedronate—osteoporosis	0.000773	0.00176	CcSEcCtD
Flurazepam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000772	0.00176	CcSEcCtD
Flurazepam—Dry mouth—Estradiol—osteoporosis	0.000771	0.00175	CcSEcCtD
Flurazepam—Asthenia—Pamidronate—osteoporosis	0.00077	0.00175	CcSEcCtD
Flurazepam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000766	0.00174	CcSEcCtD
Flurazepam—Confusional state—Estradiol—osteoporosis	0.000762	0.00173	CcSEcCtD
Flurazepam—Pruritus—Pamidronate—osteoporosis	0.00076	0.00173	CcSEcCtD
Flurazepam—Anaphylactic shock—Estradiol—osteoporosis	0.000756	0.00172	CcSEcCtD
Flurazepam—Dizziness—Risedronate—osteoporosis	0.000747	0.0017	CcSEcCtD
Flurazepam—Shock—Estradiol—osteoporosis	0.000744	0.00169	CcSEcCtD
Flurazepam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000737	0.00168	CcSEcCtD
Flurazepam—Diarrhoea—Pamidronate—osteoporosis	0.000735	0.00167	CcSEcCtD
Flurazepam—Hyperhidrosis—Estradiol—osteoporosis	0.000731	0.00166	CcSEcCtD
Flurazepam—Rash—Ethinyl Estradiol—osteoporosis	0.00073	0.00166	CcSEcCtD
Flurazepam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00073	0.00166	CcSEcCtD
Flurazepam—Headache—Ethinyl Estradiol—osteoporosis	0.000726	0.00165	CcSEcCtD
Flurazepam—Vomiting—Risedronate—osteoporosis	0.000718	0.00163	CcSEcCtD
Flurazepam—Rash—Risedronate—osteoporosis	0.000712	0.00162	CcSEcCtD
Flurazepam—Dermatitis—Risedronate—osteoporosis	0.000712	0.00162	CcSEcCtD
Flurazepam—Dizziness—Pamidronate—osteoporosis	0.00071	0.00162	CcSEcCtD
Flurazepam—Headache—Risedronate—osteoporosis	0.000708	0.00161	CcSEcCtD
Flurazepam—Asthenia—Zoledronate—osteoporosis	0.000704	0.0016	CcSEcCtD
Flurazepam—Pruritus—Zoledronate—osteoporosis	0.000694	0.00158	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000689	0.00157	CcSEcCtD
Flurazepam—Nausea—Ethinyl Estradiol—osteoporosis	0.000688	0.00157	CcSEcCtD
Flurazepam—Vomiting—Pamidronate—osteoporosis	0.000683	0.00155	CcSEcCtD
Flurazepam—Asthenia—Conjugated Estrogens—osteoporosis	0.000678	0.00154	CcSEcCtD
Flurazepam—Rash—Pamidronate—osteoporosis	0.000677	0.00154	CcSEcCtD
Flurazepam—Dermatitis—Pamidronate—osteoporosis	0.000676	0.00154	CcSEcCtD
Flurazepam—Dyspnoea—Estradiol—osteoporosis	0.000674	0.00153	CcSEcCtD
Flurazepam—Headache—Pamidronate—osteoporosis	0.000673	0.00153	CcSEcCtD
Flurazepam—Somnolence—Estradiol—osteoporosis	0.000672	0.00153	CcSEcCtD
Flurazepam—Diarrhoea—Zoledronate—osteoporosis	0.000671	0.00153	CcSEcCtD
Flurazepam—Nausea—Risedronate—osteoporosis	0.000671	0.00153	CcSEcCtD
Flurazepam—Pruritus—Conjugated Estrogens—osteoporosis	0.000668	0.00152	CcSEcCtD
Flurazepam—Dyspepsia—Estradiol—osteoporosis	0.000665	0.00151	CcSEcCtD
Flurazepam—Decreased appetite—Estradiol—osteoporosis	0.000657	0.00149	CcSEcCtD
Flurazepam—Dizziness—Zoledronate—osteoporosis	0.000649	0.00148	CcSEcCtD
Flurazepam—Constipation—Estradiol—osteoporosis	0.000646	0.00147	CcSEcCtD
Flurazepam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000646	0.00147	CcSEcCtD
Flurazepam—Nausea—Pamidronate—osteoporosis	0.000638	0.00145	CcSEcCtD
Flurazepam—Dizziness—Conjugated Estrogens—osteoporosis	0.000625	0.00142	CcSEcCtD
Flurazepam—Vomiting—Zoledronate—osteoporosis	0.000624	0.00142	CcSEcCtD
Flurazepam—Feeling abnormal—Estradiol—osteoporosis	0.000623	0.00142	CcSEcCtD
Flurazepam—Rash—Zoledronate—osteoporosis	0.000618	0.00141	CcSEcCtD
Flurazepam—Gastrointestinal pain—Estradiol—osteoporosis	0.000618	0.00141	CcSEcCtD
Flurazepam—Dermatitis—Zoledronate—osteoporosis	0.000618	0.00141	CcSEcCtD
Flurazepam—Headache—Zoledronate—osteoporosis	0.000614	0.0014	CcSEcCtD
Flurazepam—Vomiting—Conjugated Estrogens—osteoporosis	0.0006	0.00137	CcSEcCtD
Flurazepam—Rash—Conjugated Estrogens—osteoporosis	0.000595	0.00135	CcSEcCtD
Flurazepam—Dermatitis—Conjugated Estrogens—osteoporosis	0.000595	0.00135	CcSEcCtD
Flurazepam—Headache—Conjugated Estrogens—osteoporosis	0.000592	0.00135	CcSEcCtD
Flurazepam—Nausea—Zoledronate—osteoporosis	0.000583	0.00133	CcSEcCtD
Flurazepam—Nausea—Conjugated Estrogens—osteoporosis	0.000561	0.00128	CcSEcCtD
Flurazepam—Asthenia—Estradiol—osteoporosis	0.000542	0.00123	CcSEcCtD
Flurazepam—Pruritus—Estradiol—osteoporosis	0.000535	0.00122	CcSEcCtD
Flurazepam—Diarrhoea—Estradiol—osteoporosis	0.000517	0.00118	CcSEcCtD
Flurazepam—Dizziness—Estradiol—osteoporosis	0.0005	0.00114	CcSEcCtD
Flurazepam—Vomiting—Estradiol—osteoporosis	0.000481	0.00109	CcSEcCtD
Flurazepam—Rash—Estradiol—osteoporosis	0.000477	0.00108	CcSEcCtD
Flurazepam—Dermatitis—Estradiol—osteoporosis	0.000476	0.00108	CcSEcCtD
Flurazepam—Headache—Estradiol—osteoporosis	0.000474	0.00108	CcSEcCtD
Flurazepam—Nausea—Estradiol—osteoporosis	0.000449	0.00102	CcSEcCtD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	2.48e-05	0.00558	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	2.32e-05	0.00521	CbGpPWpGaD
Flurazepam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	2.32e-05	0.00521	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.29e-05	0.00515	CbGpPWpGaD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.24e-05	0.00502	CbGpPWpGaD
Flurazepam—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.21e-05	0.00496	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.17e-05	0.00489	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.07e-05	0.00466	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.07e-05	0.00466	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	2.07e-05	0.00465	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	2.04e-05	0.00458	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.98e-05	0.00445	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.97e-05	0.00444	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	1.95e-05	0.00438	CbGpPWpGaD
Flurazepam—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.95e-05	0.00438	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.93e-05	0.00433	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.9e-05	0.00428	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.89e-05	0.00424	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.89e-05	0.00424	CbGpPWpGaD
Flurazepam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.86e-05	0.00418	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	1.83e-05	0.00412	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.81e-05	0.00407	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	1.81e-05	0.00406	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.74e-05	0.00391	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—osteoporosis	1.72e-05	0.00387	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.71e-05	0.00384	CbGpPWpGaD
Flurazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.7e-05	0.00382	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.69e-05	0.0038	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.68e-05	0.00378	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.66e-05	0.00373	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.63e-05	0.00367	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.62e-05	0.00364	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.6e-05	0.0036	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.59e-05	0.00358	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.59e-05	0.00358	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.57e-05	0.00353	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.56e-05	0.00349	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—SPP1—osteoporosis	1.53e-05	0.00345	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.53e-05	0.00344	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—ADCY5—osteoporosis	1.52e-05	0.00341	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.45e-05	0.00326	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—ADCY5—osteoporosis	1.45e-05	0.00325	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—ADCY5—osteoporosis	1.45e-05	0.00325	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.44e-05	0.00323	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.43e-05	0.00322	CbGpPWpGaD
Flurazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.43e-05	0.00321	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.4e-05	0.00314	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.39e-05	0.00313	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—IRS2—osteoporosis	1.39e-05	0.00312	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.38e-05	0.0031	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.37e-05	0.00308	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.35e-05	0.00303	CbGpPWpGaD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.34e-05	0.00302	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.34e-05	0.00301	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.31e-05	0.00295	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.31e-05	0.00294	CbGpPWpGaD
Flurazepam—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.28e-05	0.00288	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.27e-05	0.00286	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.25e-05	0.00281	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.23e-05	0.00276	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.22e-05	0.00274	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	1.22e-05	0.00274	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—IRS1—osteoporosis	1.21e-05	0.00272	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.2e-05	0.00269	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—ADCY5—osteoporosis	1.19e-05	0.00268	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—ADCY5—osteoporosis	1.17e-05	0.00264	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.15e-05	0.00258	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—AGER—osteoporosis	1.14e-05	0.00256	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—ADCY5—osteoporosis	1.11e-05	0.0025	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—ADCY5—osteoporosis	1.1e-05	0.00246	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	1.09e-05	0.00245	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.09e-05	0.00245	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.06e-05	0.00237	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.05e-05	0.00235	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.04e-05	0.00233	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.03e-05	0.00232	CbGpPWpGaD
Flurazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.02e-05	0.0023	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—ADCY5—osteoporosis	1e-05	0.00225	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—ADCY5—osteoporosis	9.74e-06	0.00219	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	9.63e-06	0.00216	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—ADCY5—osteoporosis	9.61e-06	0.00216	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—ADCY5—osteoporosis	9.57e-06	0.00215	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	9.49e-06	0.00213	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—ADCY5—osteoporosis	9.4e-06	0.00211	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—ADCY5—osteoporosis	9.34e-06	0.0021	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—ADCY5—osteoporosis	9.17e-06	0.00206	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.16e-06	0.00206	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.5e-06	0.00191	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.41e-06	0.00189	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.38e-06	0.00188	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.16e-06	0.00183	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—ADCY5—osteoporosis	8.02e-06	0.0018	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.78e-06	0.00175	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.78e-06	0.00175	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—FDPS—osteoporosis	7.52e-06	0.00169	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PKM—osteoporosis	7.52e-06	0.00169	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—ADCY5—osteoporosis	7.36e-06	0.00165	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	7.34e-06	0.00165	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—POMC—osteoporosis	7.32e-06	0.00164	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PGLS—osteoporosis	7.13e-06	0.0016	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPD2—osteoporosis	7.13e-06	0.0016	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	6.97e-06	0.00157	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—FDPS—osteoporosis	6.9e-06	0.00155	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PKM—osteoporosis	6.9e-06	0.00155	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	6.88e-06	0.00155	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPD2—osteoporosis	6.54e-06	0.00147	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PGLS—osteoporosis	6.54e-06	0.00147	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ATIC—osteoporosis	6.52e-06	0.00147	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PNP—osteoporosis	6.52e-06	0.00147	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.41e-06	0.00144	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.31e-06	0.00142	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.23e-06	0.0014	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—osteoporosis	6.02e-06	0.00135	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PNP—osteoporosis	5.99e-06	0.00135	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ATIC—osteoporosis	5.99e-06	0.00135	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.97e-06	0.00134	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.9e-06	0.00132	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—POMC—osteoporosis	5.78e-06	0.0013	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.76e-06	0.0013	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—OXCT1—osteoporosis	5.54e-06	0.00125	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CA2—osteoporosis	5.54e-06	0.00125	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FDPS—osteoporosis	5.46e-06	0.00123	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PKM—osteoporosis	5.46e-06	0.00123	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MGLL—osteoporosis	5.4e-06	0.00121	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.39e-06	0.00121	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.24e-06	0.00118	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPD2—osteoporosis	5.17e-06	0.00116	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PGLS—osteoporosis	5.17e-06	0.00116	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.14e-06	0.00116	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CA2—osteoporosis	5.09e-06	0.00114	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—OXCT1—osteoporosis	5.09e-06	0.00114	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	5.06e-06	0.00114	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.06e-06	0.00114	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.05e-06	0.00114	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.02e-06	0.00113	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MGLL—osteoporosis	4.96e-06	0.00111	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.93e-06	0.00111	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	4.81e-06	0.00108	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ATIC—osteoporosis	4.73e-06	0.00106	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PNP—osteoporosis	4.73e-06	0.00106	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.68e-06	0.00105	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—IDH2—osteoporosis	4.59e-06	0.00103	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.47e-06	0.001	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.45e-06	0.001	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.4e-06	0.00099	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—osteoporosis	4.37e-06	0.000982	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP27A1—osteoporosis	4.32e-06	0.000971	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.31e-06	0.000969	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—IDH2—osteoporosis	4.22e-06	0.000948	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ACP5—osteoporosis	4.2e-06	0.000944	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FDPS—osteoporosis	4.11e-06	0.000923	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PKM—osteoporosis	4.11e-06	0.000923	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	4.08e-06	0.000917	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CA2—osteoporosis	4.02e-06	0.000904	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—OXCT1—osteoporosis	4.02e-06	0.000904	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP27A1—osteoporosis	3.97e-06	0.000891	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.96e-06	0.000889	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MGLL—osteoporosis	3.92e-06	0.000881	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TPI1—osteoporosis	3.91e-06	0.000878	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PGLS—osteoporosis	3.89e-06	0.000875	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPD2—osteoporosis	3.89e-06	0.000875	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ACP5—osteoporosis	3.86e-06	0.000867	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.85e-06	0.000866	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—P4HB—osteoporosis	3.67e-06	0.000825	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GAPDH—osteoporosis	3.6e-06	0.00081	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TPI1—osteoporosis	3.59e-06	0.000806	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PNP—osteoporosis	3.56e-06	0.0008	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ATIC—osteoporosis	3.56e-06	0.0008	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—RAP1A—osteoporosis	3.51e-06	0.000789	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—P4HB—osteoporosis	3.37e-06	0.000758	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—IDH2—osteoporosis	3.33e-06	0.000749	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GAPDH—osteoporosis	3.31e-06	0.000744	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—RAP1A—osteoporosis	3.22e-06	0.000724	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP27A1—osteoporosis	3.13e-06	0.000704	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ACP5—osteoporosis	3.05e-06	0.000685	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—OXCT1—osteoporosis	3.03e-06	0.000681	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CA2—osteoporosis	3.03e-06	0.000681	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MGLL—osteoporosis	2.95e-06	0.000663	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ENO1—osteoporosis	2.84e-06	0.000638	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TPI1—osteoporosis	2.83e-06	0.000637	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PSMA5—osteoporosis	2.8e-06	0.000628	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PSMA2—osteoporosis	2.8e-06	0.000628	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—POMC—osteoporosis	2.68e-06	0.000603	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—P4HB—osteoporosis	2.66e-06	0.000599	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GAPDH—osteoporosis	2.62e-06	0.000588	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ENO1—osteoporosis	2.61e-06	0.000586	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PSMA2—osteoporosis	2.57e-06	0.000577	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PSMA5—osteoporosis	2.57e-06	0.000577	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—RAP1A—osteoporosis	2.55e-06	0.000572	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PKM—osteoporosis	2.53e-06	0.000569	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FDPS—osteoporosis	2.53e-06	0.000569	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—IDH2—osteoporosis	2.51e-06	0.000564	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PGLS—osteoporosis	2.4e-06	0.000539	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPD2—osteoporosis	2.4e-06	0.000539	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP27A1—osteoporosis	2.36e-06	0.00053	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.32e-06	0.00052	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.31e-06	0.000519	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ACP5—osteoporosis	2.3e-06	0.000516	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP19A1—osteoporosis	2.27e-06	0.00051	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PNP—osteoporosis	2.19e-06	0.000493	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ATIC—osteoporosis	2.19e-06	0.000493	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.16e-06	0.000486	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.16e-06	0.000485	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TPI1—osteoporosis	2.13e-06	0.00048	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP19A1—osteoporosis	2.08e-06	0.000468	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ENO1—osteoporosis	2.06e-06	0.000463	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PSMA2—osteoporosis	2.03e-06	0.000456	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PSMA5—osteoporosis	2.03e-06	0.000456	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—P4HB—osteoporosis	2.01e-06	0.000451	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GAPDH—osteoporosis	1.97e-06	0.000443	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—RAP1A—osteoporosis	1.92e-06	0.000431	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CA2—osteoporosis	1.87e-06	0.000419	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—OXCT1—osteoporosis	1.87e-06	0.000419	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ADCY5—osteoporosis	1.85e-06	0.000417	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPX1—osteoporosis	1.85e-06	0.000415	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MGLL—osteoporosis	1.82e-06	0.000409	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MTHFR—osteoporosis	1.71e-06	0.000383	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ADCY5—osteoporosis	1.7e-06	0.000382	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPX1—osteoporosis	1.7e-06	0.000381	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.65e-06	0.00037	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MTHFR—osteoporosis	1.57e-06	0.000352	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ENO1—osteoporosis	1.55e-06	0.000348	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—IDH2—osteoporosis	1.55e-06	0.000347	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PSMA2—osteoporosis	1.53e-06	0.000343	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PSMA5—osteoporosis	1.53e-06	0.000343	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.45e-06	0.000327	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ACP5—osteoporosis	1.41e-06	0.000318	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—POMC—osteoporosis	1.36e-06	0.000306	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ADCY5—osteoporosis	1.34e-06	0.000302	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPX1—osteoporosis	1.34e-06	0.000301	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TPI1—osteoporosis	1.31e-06	0.000295	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—POMC—osteoporosis	1.25e-06	0.000281	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP19A1—osteoporosis	1.24e-06	0.000279	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MTHFR—osteoporosis	1.24e-06	0.000278	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—P4HB—osteoporosis	1.24e-06	0.000278	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GAPDH—osteoporosis	1.21e-06	0.000273	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—RAP1A—osteoporosis	1.18e-06	0.000266	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ADCY5—osteoporosis	1.01e-06	0.000228	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPX1—osteoporosis	1.01e-06	0.000227	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—POMC—osteoporosis	9.89e-07	0.000222	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ENO1—osteoporosis	9.55e-07	0.000215	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PSMA2—osteoporosis	9.41e-07	0.000212	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PSMA5—osteoporosis	9.41e-07	0.000212	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MTHFR—osteoporosis	9.31e-07	0.000209	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.64e-07	0.000172	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—POMC—osteoporosis	7.45e-07	0.000167	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ADCY5—osteoporosis	6.24e-07	0.00014	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPX1—osteoporosis	6.22e-07	0.00014	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MTHFR—osteoporosis	5.74e-07	0.000129	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—POMC—osteoporosis	4.59e-07	0.000103	CbGpPWpGaD
